← Back to Search

Smoking Cessation and Health & Wellness for Acute Coronary Syndrome

Waitlist Available
Led By Andrew Busch, PhD
Research Sponsored by Hennepin Healthcare Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age of 18-75 years
Hospital inpatients with an ACS diagnosis documented in medical record within the past 30 days
Must not have
Be younger than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up5 years
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test whether a single, integrated treatment that targets both depressed mood and smoking is more effective than usual care in reducing post-acute coronary syndrome mortality.

Eligible Conditions
  • Acute Coronary Syndrome
  • Tobacco Use

Eligibility Criteria

Inclusion Criteria

You will be eligible if you check “Yes” for the criteria below
You are between 18 and 75 years old.
You have been diagnosed with acute coronary syndrome and have been in the hospital in the past 30 days.
You smoked at least one cigarette per day before being hospitalized.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
7-day point prevalence abstinence from smoking
Depression Symptoms
Secondary outcome measures
Blood Bio-markers
Continuous Abstinence From Smoking Since Hospital Discharge
Depressed mood
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BAT-CSExperimental Treatment1 Intervention
Participants will receive standard smoking cessation plus Behavioral Activation based mood management. Will be offered the nicotine patch if medically cleared.
Group II: Smoking Cessation and Health & WellnessActive Control1 Intervention
Participants will receive standard smoking cessation plus health and wellness education. Will be offered the nicotine patch if medically cleared.

Find a Location

Who is running the clinical trial?

Hennepin Healthcare Research InstituteLead Sponsor
88 Previous Clinical Trials
76,441 Total Patients Enrolled
6 Trials studying Acute Coronary Syndrome
7,435 Patients Enrolled for Acute Coronary Syndrome
Minneapolis Heart Institute FoundationOTHER
29 Previous Clinical Trials
15,232 Total Patients Enrolled
1 Trials studying Acute Coronary Syndrome
32 Patients Enrolled for Acute Coronary Syndrome
The Miriam HospitalOTHER
235 Previous Clinical Trials
36,584 Total Patients Enrolled
3 Trials studying Acute Coronary Syndrome
88 Patients Enrolled for Acute Coronary Syndrome

Media Library

BAT-CS Clinical Trial Eligibility Overview. Trial Name: NCT03413423 — N/A
Acute Coronary Syndrome Research Study Groups: BAT-CS, Smoking Cessation and Health & Wellness
Acute Coronary Syndrome Clinical Trial 2023: BAT-CS Highlights & Side Effects. Trial Name: NCT03413423 — N/A
BAT-CS 2023 Treatment Timeline for Medical Study. Trial Name: NCT03413423 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which population would be best suited to participate in this experiment?

"For this trial, 324 individuals aged 18 to 75 with a recent diagnosis of acute coronary syndrome are required. These participants must also possess the following attributes: fluency in English, smoking history of at least 1 cigarette per day prior to hospitalization, inpatient status, access to or willingness to use a study issued cell phone and agreement for consenting all trial procedures including potential quitting from smoking upon discharge."

Answered by AI

Is the enrollment process for this clinical research still open?

"Indeed, clinicaltrials.gov has verified that this trial is actively searching for volunteers to join their study. This experiment was initially posted on January 29th 2018 and the latest update occurred on August 2nd 2022."

Answered by AI

Is eligibility for this research endeavor limited to persons aged 60 and over?

"The age range of eligible patients for this study is between 18 years old and 75 years old."

Answered by AI

What is the projected enrolment size of this research endeavor?

"Affirmative. The details hosted on clinicaltrials.gov suggest that this experiment, which was first introduced to the public on 29th January 2018 is currently in need of enrolment. A total of 324 patients are required from 1 medical facility."

Answered by AI

What objectives does this experiment seek to achieve?

"This clinical trial will run for 12 months with the main objective of evaluating Depression Symptoms. Secondary objectives include testing Blood Bio-markers (HDL, LDL, High Sensitivity C-reactive protein and Fibrinogen), determining Resting Systolic and Diastolic Blood Pressure levels, as well as assessing Treatment Acceptability through a Client Satisfaction Questionnaire."

Answered by AI
~18 spots leftby May 2024